Follicular Lymphoma Involving Bilateral Ovaries Following Routine Hysterectomy and Bilateral Salpingo-Oophorectomy: An Incidental Finding

Anoshia Afzal, M. Quinton, U. Farooque, S. Asadbeigi, B. Khan, S. Khan
{"title":"Follicular Lymphoma Involving Bilateral Ovaries Following Routine Hysterectomy and Bilateral Salpingo-Oophorectomy: An Incidental Finding","authors":"Anoshia Afzal, M. Quinton, U. Farooque, S. Asadbeigi, B. Khan, S. Khan","doi":"10.20944/preprints202012.0347.v1","DOIUrl":null,"url":null,"abstract":"Ovarian lymphoma is an infrequent disease, accounting for less than 1% of all non-Hodgkin lymphoma diagnosis. Symptoms include abnormal vaginal bleeding or discharge, abdominal pain, and urinary obstruction due to the large mass. In our case, a 60-year-old woman, underwent a total abdominal hysterectomy and bilateral salpingo-oophorectomy, as she presented with low-grade follicular lymphoma (FL) in both the ovaries, and the left ovary was observed to be enlarged. The tumor is categorized as lymphoma based upon immunohistochemical markers. Computed tomography (CT) scan of the chest, abdomen, and pelvis and bone marrow biopsy are important for the staging of primary lymphoma of the ovary. The first-line chemotherapy regimen includes rituximab, cyclophosphamide, doxorubicin hydrochloride (hydroxydaunorubicin), vincristine sulfate (Oncovin), and prednisone (R-CHOP) for rapidly proliferative non-Hodgkin lymphoma (NHL). Lymphomas with slower growth patterns can be treated with Bendamustine-Rituximab and don’t need aggressive R-CHOP treatment.","PeriodicalId":247564,"journal":{"name":"International Journal on Oncology and Radiotherapy","volume":"41 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2020-12-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal on Oncology and Radiotherapy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.20944/preprints202012.0347.v1","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Ovarian lymphoma is an infrequent disease, accounting for less than 1% of all non-Hodgkin lymphoma diagnosis. Symptoms include abnormal vaginal bleeding or discharge, abdominal pain, and urinary obstruction due to the large mass. In our case, a 60-year-old woman, underwent a total abdominal hysterectomy and bilateral salpingo-oophorectomy, as she presented with low-grade follicular lymphoma (FL) in both the ovaries, and the left ovary was observed to be enlarged. The tumor is categorized as lymphoma based upon immunohistochemical markers. Computed tomography (CT) scan of the chest, abdomen, and pelvis and bone marrow biopsy are important for the staging of primary lymphoma of the ovary. The first-line chemotherapy regimen includes rituximab, cyclophosphamide, doxorubicin hydrochloride (hydroxydaunorubicin), vincristine sulfate (Oncovin), and prednisone (R-CHOP) for rapidly proliferative non-Hodgkin lymphoma (NHL). Lymphomas with slower growth patterns can be treated with Bendamustine-Rituximab and don’t need aggressive R-CHOP treatment.
常规子宫切除术及双侧输卵管卵巢切除术后发生双侧卵巢滤泡性淋巴瘤:偶然发现
卵巢淋巴瘤是一种罕见的疾病,占所有非霍奇金淋巴瘤诊断的不到1%。症状包括阴道异常出血或分泌物,腹痛,以及由大肿块引起的尿路梗阻。在我们的病例中,一名60岁的女性,由于双侧卵巢出现低级别滤泡性淋巴瘤(FL),左侧卵巢肿大,接受了全腹部子宫切除术和双侧输卵管卵巢切除术。根据免疫组织化学标记物将肿瘤分类为淋巴瘤。胸部、腹部、骨盆的计算机断层扫描(CT)和骨髓活检对卵巢原发性淋巴瘤的分期很重要。一线化疗方案包括利妥昔单抗、环磷酰胺、盐酸多柔比星(hydroxydaunorubicin)、硫酸长春新碱(Oncovin)和强的松(R-CHOP)治疗快速增殖性非霍奇金淋巴瘤(NHL)。生长模式较慢的淋巴瘤可以用苯达莫司汀-利妥昔单抗治疗,不需要积极的R-CHOP治疗。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信